Literature DB >> 23818040

Anti-tumor necrosis factor and new bone formation in ankylosing spondylitis: the controversy continues.

Pedro Machado1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23818040     DOI： 10.1002/art.38068

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

1.  The osteogenic potential of ligament fibroblasts is greater in ankylosing spondylitis patients than in patients with osteoarthritis.

Authors:  M Yang; H Yuan; M Miao; W Xu
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

2.  Spondyloarthropathies: Sacroiliac joint radiographic progression - speed and determinants.

Authors:  Victoria Navarro-Compán; Pedro M Machado
Journal:  Nat Rev Rheumatol       Date:  2016-05-26       Impact factor: 20.543

Review 3.  The role of IL-1β in the bone loss during rheumatic diseases.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Carubbi; Vasiliki Liakouli; Francesca Zazzeroni; Paola Di Benedetto; Onorina Berardicurti; Edoardo Alesse; Roberto Giacomelli
Journal:  Mediators Inflamm       Date:  2015-04-12       Impact factor: 4.711

Review 4.  Biologic agents in juvenile spondyloarthropathies.

Authors:  María Martha Katsicas; Ricardo Russo
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-12       Impact factor: 3.054

Review 5.  Efficacy and safety of adalimumab in ankylosing spondylitis.

Authors:  Aziza Mounach; Abdellah El Maghraoui
Journal:  Open Access Rheumatol       Date:  2014-08-13

6.  TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.

Authors:  Christoph Molnar; Almut Scherer; Xenofon Baraliakos; Manouk de Hooge; Raphael Micheroli; Pascale Exer; Rudolf O Kissling; Giorgio Tamborrini; Lukas M Wildi; Michael J Nissen; Pascal Zufferey; Jürg Bernhard; Ulrich Weber; Robert B M Landewé; Désirée van der Heijde; Adrian Ciurea
Journal:  Ann Rheum Dis       Date:  2017-09-22       Impact factor: 19.103

7.  Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.

Authors:  Jun Won Park; Min Jung Kim; Jeong Seok Lee; You-Jung Ha; Jin Kyun Park; Eun Ha Kang; Yun Jong Lee; Yeong Wook Song; Eun Young Lee
Journal:  Arthritis Rheumatol       Date:  2018-11-12       Impact factor: 10.995

8.  Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS.

Authors:  Désirée van der Heijde; Robert Landewé
Journal:  Arthritis Res Ther       Date:  2019-11-06       Impact factor: 5.156

9.  Might axial myofascial properties and biomechanical mechanisms be relevant to ankylosing spondylitis and axial spondyloarthritis?

Authors:  Alfonse T Masi
Journal:  Arthritis Res Ther       Date:  2014-04-08       Impact factor: 5.156

Review 10.  Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis.

Authors:  Désirée van der Heijde; Jürgen Braun; Atul Deodhar; Xenofon Baraliakos; Robert Landewé; Hanno B Richards; Brian Porter; Aimee Readie
Journal:  Rheumatology (Oxford)       Date:  2019-03-01       Impact factor: 7.580
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.